GlassScriptPhysician profile
Benjamin Paul Neff
NPI 1386106060
$6,096.93
in general payments reported to CMS, 2019-2025
41 companies · $1,931 in 2025
The $1,931 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $583 · 2023: $1,476 · 2024: $2,107 · 2025: $1,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,413 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,413.49 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,530.78 | 2022-2025 | |
| Lilly USA, LLC | $424.66 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $405.83 | 2022-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $396.08 | 2023-2025 | |
| Viiv Healthcare Company | $389.96 | 2023-2025 | Apretude |
| Astellas Pharma US INC | $288.84 | 2023-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.30 | 2022-2025 | Jardiance, Synjardy |
| Corcept Therapeutics | $229.14 | 2024-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $222.24 | 2022-2025 | |
| Glaxosmithkline, LLC. | $216.64 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Otsuka America Pharmaceutical, INC. | $181.82 | 2023-2025 | Rexulti |
| Gilead Sciences, INC. | $161.02 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $160.88 | 2022-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Novo Nordisk INC | $124.66 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $122.52 | 2022-2025 | Spravato, Xarelto |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $95.80 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Astrazeneca Pharmaceuticals LP | $94.78 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $79.47 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.92 | 2025 | Caplyta |
| Lucid Diagnostics INC. | $63.44 | 2022-2023 | |
| Axsome Therapeutics, INC. | $57.63 | 2023-2025 | Auvelity, Sunosi |
| Sanofi-Aventis U.S. LLC | $41.84 | 2022 | |
| Phathom Pharmaceuticals, INC. | $41.68 | 2025 | Voquezna |
| Inspire Medical Systems, INC. | $40.55 | 2024 | Inspire |
| Boston Scientific Corporation | $37.67 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Dexcom, INC. | $36.83 | 2022-2025 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $34.98 | 2022 | |
| Idorsia Pharmaceuticals US INC | $31.93 | 2022 | |
| Organon LLC | $27.19 | 2024-2025 | Nexplanon |
| Edwards Lifesciences Corporation | $24.67 | 2025 | Sapien 3 Ultra Resilia |
| Xeris Pharmaceuticals, INC. | $24.03 | 2023 | Gvoke Hypopen |
| Exeltis, USA INC. | $21.18 | 2024 | Slynd |
| Shield Therapeutics INC | $20.47 | 2024 | |
| Sanofi Pasteur INC. | $18.59 | 2024 | |
| Dynavax Technologies Corporation | $17.30 | 2023 | Heplisav-B |
| Tris Pharma INC | $15.33 | 2023 | Dyanavel Xr |
| Tactile Systems Technology INC | $14.02 | 2023 | Flexitouch Plus, Entre Plus |
| Verity Pharmaceuticals INC. | $13.94 | 2025 | Tlando |
| Medtronic, INC. | $13.56 | 2025 | Minimed 780g |
| Exact Sciences Corporation | $13.10 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.